Med-Tech
Bitterroot Bio Raises $145M in Series A to Revolutionize Cardio-Immunology Medicines
Bitterroot Bio, a biotechnology company focused on developing novel immunot...
Omniscient's MRI-Enhanced Brain Analysis Receives FDA Clearance
Omniscient, the world leader in using AI to decode the human brain, today a...
Anthill Ventures invites applications for Lumos Health Programme to support health tech startups
Anthill Ventures, a leading global venture capital firm and speed-scaling...
Profound Medical Secures CPT Category 1 Codes for TULSA in Prostate Disease Treatment
Profound Medical Corp., a commercial-stage medical device company that deve...
Dental care startup Smiles.ai rebrands as Dezy, plans to clock Rs 300 Cr by FY25
Having strengthened its foothold as a premium specialist in the dental care...
Treace Medical Concepts Acquires Patient-Specific Instrumentation Technology for Foot and Ankle Surgeries
Treace Medical Concepts, Inc., a medical technology company driving a funda...
Elicio Therapeutics Successfully Merges with Angion Biomedica
Elicio Therapeutics, a clinical-stage biotechnology company developing a pi...
AtomVie Global Radiopharma Secures $90M for Facility Buildout
AtomVie Global Radiopharma Inc., a global-leading CDMO for the GMP manufact...
Trethera Secures $2M NCI Grant for Biomarker Advancement in Phase 1 Trial
Trethera Corporation, a clinical stage biopharmaceutical company committed ...
Awshad Ventures into Mushroom Wellness Market, Launches Calmashroom CBD and Cordyceps Capsules
A New Delhi-based medical cannabis wellness start-up Awshad has now venture...
Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical ...
C-CAMP receives CSR support from Cytiva to foster early-stage innovations in India
Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) has re...
AstriVax Receives €2.5M Grant to Advance Vaccine Platform
AstriVax is pleased to announce that it has been selected for funding by Fl...
FDA Approves Lexicon's INPEFA (sotagliflozin) for Heart Failure
Lexicon Pharmaceuticals, Inc. today announced that the U.S. Food and Drug A...
TScan Therapeutics Successfully Prices $140 Million Public Offering
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company focuse...
Sunstone Therapies' Psilocybin Therapy Shows Long-Term Benefits for MDD in Cancer Patients: ASCO Study
Sunstone Therapies, a leader in the development of clinical trials and the ...
Tempest Presents Phase 1 Data on TPST-1495 in Advanced Cancers at ASCO
Tempest Therapeutics, Inc., a clinical-stage oncology company developing fi...
AXIM Biotechnologies Secures 40+ Clinics for Diagnostic Assay Platform Launch
Axim biotechnologies, an international healthcare diagnostic solutions deve...
